Virus News and Research

Latest Virus News and Research

NIH-funded study explores disparities in achieving HIV suppression

Daily antiretroviral therapy that suppresses HIV to levels undetectable by standard blood tests is lifesaving for individuals living with HIV and prevents sexual transmission of the virus to others.

22 Aug 2018

Screening for HPV could replace routine Pap smears

According to health advisors from the U.S. Preventive Services Task Force, Pap smears may not be the only way to check for cervical cancer risk among women.

22 Aug 2018

Comprehensive analysis informs new recommendation for national cervical cancer screening

A comprehensive analysis of eight clinical trials and four cohort studies on cervical cancer screening by researchers from UC Davis and Kaiser Permanente Northwest has found that while Pap smears are still highly effective for detecting pre-cancerous cells and cancer, testing for the virus that causes these cancers also is an excellent screening tool.

21 Aug 2018

Genital warts may promote HIV sexual transmission

A new study has shown that genital warts may promote HIV sexual transmission and, in turn, their treatment and prevention could help decrease the spread of the disease.

21 Aug 2018

Scientists find two molecules that may combat cancer and chronic infections

To fight viral infections, your immune system calls on CD8 T cells to kill the infected cells. The CD8 T cells can also be used in immunotherapy approaches to kill cancer cells, including the CAR T cell therapy currently attracting broad public attention.

21 Aug 2018

Promising data supports development of AAVhu37-based gene therapy for hemophilia A

Gene therapy using an optimized adeno-associated virus to deliver the human factor VIII gene to cynomolgus macaques showed a substantial increase in hFVIII expression and no detectable antibody response for 30 weeks in some animals.

21 Aug 2018

Researchers find STAT3 as therapeutic target for chronic active EBV infection

Tokyo Medical and Dental University study shows that ruxolitinib-induced inhibition of STAT3 activity blocks survival and reduces pro-inflammatory cytokine production in Epstein-Barr virus (EBV)-infected clonally proliferating T- or NK-cells in Chronic active Epstein-Barr virus infection.

20 Aug 2018

Infection rates of high risk oral HPV in England found to be lower than expected

Infection rates of high risk human papillomavirus (HR-HPV) oral infection in England are lower than expected, compared to previous US studies.

20 Aug 2018

New modeling studies highlight urgent need for effective drug policy reforms to prevent HIV

While global incidence rates of HIV have declined notably in recent years, the virus that causes AIDS remains a major and, in some ways largely unmitigated, public health threat in some countries and regions.

17 Aug 2018

Ology Bioservices wins $8.4 million worth agreement to manufacture anti-Ebola monoclonal antibody

Ology Bioservices, Inc., a biologics contract development and manufacturing organization, announced today that it was awarded an Other Transaction Agreement to support the Joint Project Manager Medical Countermeasure Systems, a component of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense for advanced biologics manufacturing services—specifically, to manufacture an anti-Ebola monoclonal antibody.

17 Aug 2018

Researchers develop new approach to study how tuberculosis infects people

Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected.

17 Aug 2018

Transgenic rice plant extracts could help stop the spread of HIV

Extracts from transgenic rice plants could help stop the spread of HIV, according to research results from an international effort that included an Iowa State University scientist.

17 Aug 2018

Discovery may help broaden the scope of defenses against HPV

Yale Cancer Center scientists have filled in a key gap in understanding the unusual route by which the Human papillomavirus infects cells.

16 Aug 2018

Researchers use super-resolution microscope to unravel secrets of deadly Nipah virus

The deadly Nipah virus and others like it assemble themselves in a much more haphazard manner than previously thought, new UBC research has found. The discovery could allow scientists to develop more effective vaccines and rule out many approaches to fighting these viruses.

16 Aug 2018

NIH begins first-in-human trial of experimental live, attenuated Zika virus vaccine

Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

16 Aug 2018

New HIV therapy suppresses viral replication and increases immune cells in drug-resistant patients

In a study, a new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with existing HIV medications, the drug is a promising strategy for patients who have run out of effective treatment options, the researchers said.

16 Aug 2018

Study uncovers mechanism that affects multiplication of dengue virus lineage

A lineage of type 1 dengue virus found in Brazil is able to prevail over another even though it multiplies less in vector mosquitoes and infected human cells.

15 Aug 2018

New polyclonal immunotherapy successfully neutralizes Ebola virus

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided "100% protection against a lethal dose of the Ebola virus" in a recent animal study published in The Journal of Infectious Diseases.

15 Aug 2018

Ebola outbreak in Congo spreads to active combat zone

The outbreak of the deadly Ebola in the Democratic Republic of Congo has spread outside the province of North Kivu according to a statement made by the country’s health ministry yesterday. With this the viral infection has reached an active conflict zone and this may mean that it could spread wider now.

14 Aug 2018

Simple intervention during routine care reduces alcohol consumption in men with HIV

Among the more than 1 million people in the U.S. living with HIV, 19 percent meet the criteria for an alcohol use disorder.

14 Aug 2018

Virus News and Research

Latest Virus News and Research

NIH-funded study explores disparities in achieving HIV suppression

Screening for HPV could replace routine Pap smears

Comprehensive analysis informs new recommendation for national cervical cancer screening

Genital warts may promote HIV sexual transmission

Scientists find two molecules that may combat cancer and chronic infections

Promising data supports development of AAVhu37-based gene therapy for hemophilia A

Researchers find STAT3 as therapeutic target for chronic active EBV infection

Infection rates of high risk oral HPV in England found to be lower than expected

New modeling studies highlight urgent need for effective drug policy reforms to prevent HIV

Ology Bioservices wins $8.4 million worth agreement to manufacture anti-Ebola monoclonal antibody

Researchers develop new approach to study how tuberculosis infects people

Transgenic rice plant extracts could help stop the spread of HIV

Discovery may help broaden the scope of defenses against HPV

Researchers use super-resolution microscope to unravel secrets of deadly Nipah virus

NIH begins first-in-human trial of experimental live, attenuated Zika virus vaccine

New HIV therapy suppresses viral replication and increases immune cells in drug-resistant patients

Study uncovers mechanism that affects multiplication of dengue virus lineage

New polyclonal immunotherapy successfully neutralizes Ebola virus

Ebola outbreak in Congo spreads to active combat zone

Simple intervention during routine care reduces alcohol consumption in men with HIV

A new way of characterising biomolecules eBook

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Newsletters you may be interested in